Explore Our Blog: Expert Articles and Updates​

Posts by:

Segal Trials

Exploring a New Path for Anxiety Relief: Inside Psychedelic Research

What if anxiety care didn’t mean taking a pill every day or endlessly pushing through talk therapy that doesn’t quite stick? A growing number of researchers are asking that same question—and turning their attention to a new possibility: psychedelic-assisted therapy. Currently under investigation in advanced clinical trials, this approach combines guided psychedelic sessions with therapeutic support to explore how it may impact people living with chronic anxiety.

Read More

What Happens When Antidepressants Aren’t Enough?

For many, depression is an invisible battle — a daily weight that colors every thought, decision, and moment. While some find relief through therapy or antidepressants, others continue to struggle despite trying multiple medications. This is known as treatment-resistant depression (TRD), and it affects a significant number of people diagnosed with Major Depressive Disorder (MDD).

Read More

Exploring Psychedelic Research for Generalized Anxiety Disorder

Anxiety isn’t always fleeting. For millions of adults, it’s a daily, debilitating experience.
Generalized Anxiety Disorder (GAD) affects approximately 3.1% of U.S. adults each year, and many find limited relief even after trying traditional medications like SSRIs or benzodiazepines[^1]. Symptoms often include excessive worry, restlessness, sleep disturbances, and difficulty concentrating — lasting six months or more and affecting relationships, work, and daily life.

Read More

When Schizophrenia Escalates: Understanding Acute Psychotic Episodes

What Is an Acute Psychotic Episode?

For people living with schizophrenia, there can be long stretches of stability — but sometimes, symptoms return suddenly and powerfully. These surges are known as acute psychotic episodes.

Read More